Sustained clinical effectiveness of interferon-β-1b in multiple sclerosis patients

被引：0
|
作者：
Shimpi, AV
Layton, B
Bashir, K
机构：
来源：
ANNALS OF NEUROLOGY | 2004年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [21] Interferon-β1b in multiple sclerosis therapy: More than 20 years clinical experience [Interferon-β1b in der Multiple-Sklerose-Therapie: Mehr als 20 Jahre klinische Erfahrung]
    Hartung H.-P.
    Haas J.
    Meergans M.
    Tracik F.
    Ortler S.
    Der Nervenarzt, 2013, 84 (6) : 679 - 704
  • [22] Spotlight on interferon-β-1b in relapsing-remitting and secondary progressive multiple sclerosis
    McCormack, PL
    Scott, LJ
    BIODRUGS, 2004, 18 (05) : 343 - 347
  • [23] Interferon-β-1b in multiple sclerosis:: comparing two different doses (the OPTIMS Study)
    Durelli, L
    Verdun, E
    Barbero, P
    Pipieri, A
    Ricci, A
    Clerico, M
    Gucci, MA
    Giordano, L
    Bergui, M
    Versino, E
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S248 - S248
  • [24] Spotlight on Interferon-β-1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
    Paul L. McCormack
    Lesley J. Scott
    BioDrugs, 2004, 18 : 343 - 347
  • [25] No evidence for increased frequency of autoantibodies during interferon-β1b treatment of multiple sclerosis
    Kivisakk, P
    Lundahl, J
    von Heigl, Z
    Fredrikson, S
    ACTA NEUROLOGICA SCANDINAVICA, 1998, 97 (05): : 320 - 323
  • [26] Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain
    Fernandez, Oscar
    Agueera, Javier
    Izquierdo, Guillermo
    Millan-Pascual, Javier
    Ramio i Torrenta, Lluis
    Oliva, Pedro
    Argente, Javier
    Berdei, Yasmina
    Maria Soler, Jose
    Carmona, Olga
    Maria Errea, Jose
    Farres, Jordi
    PLOS ONE, 2012, 7 (05):
  • [27] Treatment of patients with secondary progressive multiple sclerosis with interferon β-1b
    Robert P. Lisak
    Current Neurology and Neuroscience Reports, 2001, 1 (3) : 246 - 248
  • [28] Alpha-tocopherol and NADPH in the erythrocytes and plasma of multiple sclerosis patients -: Effect of interferon-β-1b treatment
    Karg, E
    Klivenyi, P
    Bencsik, K
    Turi, S
    Vecsei, L
    EUROPEAN NEUROLOGY, 2003, 50 (04) : 215 - 219
  • [29] The effects of interferon-β1b on expression of CXCR3 on circulating T cells in multiple sclerosis patients
    Nakajima, H.
    Hosokawa, T.
    Sugino, M.
    Kimura, F.
    Hanafusa, T.
    Ikemoto, T.
    Shimizu, A.
    8TH INTERNATIONAL CONGRESS OF NEUROIMMUNOLOGY, 2006, : 79 - 83
  • [30] Interferon-β1b augments activation-induced T-cell death in multiple sclerosis patients
    Kaser, A
    Deisenhammer, F
    Berger, T
    Tilg, H
    LANCET, 1999, 353 (9162): : 1413 - 1414
12345